YaoGeJu

Company directoryChina company filings

Zhejiang Jiangbei Pharmaceutical Co., Ltd.

As of 18 November 2026, for the company name Zhejiang Jiangbei Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 9 active records with this name as holder; 12 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

19 acceptance records as first applicant, grouped into 14 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Ezetimibe Tablets 1 records · Latest accepted 2026/10/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602544Generic2026/10/14Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Probucol Tablets 1 records · Latest accepted 2026/08/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601948Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin Tablets 2 records · Latest accepted 2026/08/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601938Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
CYHS2601937Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Ticagrelor Tablets 2 records · Latest accepted 2025/12/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504240Generic2025/12/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
CYHS2500786Generic2025/02/18Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/11/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504116Generic2025/11/29Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Ezetimibe and Atorvastatin Calcium Tablets(II) 1 records · Latest accepted 2025/10/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503643Generic2025/10/14Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Empagliflozin Tablets 1 records · Latest accepted 2025/06/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502147Generic2025/06/17Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Benzbromarone Tablets 1 records · Latest accepted 2025/04/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501591Generic2025/04/28Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2025/03/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500995Generic2025/03/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets 2 records · Latest accepted 2024/12/17

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404380Generic2024/12/17Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
CYHS2404379Generic2024/12/17Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Trazodone Hydrochloride Tablets 1 records · Latest accepted 2024/08/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402827Generic2024/08/30Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Pioglitazone and Metformin Hydrochloride Tablets 1 records · Latest accepted 2024/06/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401853Generic2024/06/21Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Rosuvastatin Calcium Tablets 2 records · Latest accepted 2022/10/11

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201850Supplement2022/10/11Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
CYHB2201849Supplement2022/10/11Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Levetiracetam Tablets 2 records · Latest accepted 2022/04/19

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200609Generic2022/04/19Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
CYHS2200608Generic2022/04/19Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

5 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 2 applicationsAccepted: 1 applicationNo longer listed under review: 2 applications

  1. 2026/11/10Marketing application approved

    Empagliflozin Tablets

    CYHS2502147 · 国药准字H20266571

    Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14

    View source · Table row 89 ↗
  2. 2026/11/10Marketing application approved

    Benzbromarone Tablets

    CYHS2501591 · 国药准字H20266559

    Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14

    View source · Table row 62 ↗
  3. 2026/10/28No longer listed under review

    Empagliflozin Tablets

    CYHS2502147

    Fact date: 2026/10/28 · Date added to this site: 2026/10/28

    Accepted: 2025/06/17

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266571; approval date: 2026/11/10) · NMPA source · row 89

    NMPA · Table row 89 ↗ View source ↗
  4. 2026/10/28No longer listed under review

    Benzbromarone Tablets

    CYHS2501591

    Fact date: 2026/10/28 · Date added to this site: 2026/10/28

    Accepted: 2025/04/28

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266559; approval date: 2026/11/10) · NMPA source · row 62

    NMPA · Table row 62 ↗ View source ↗
  5. 2026/10/14Accepted

    Ezetimibe Tablets

    CYHS2602544

    Fact date: 2026/10/14 · Date added to this site: 2026/10/22

    View source ↗

Under review

7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Ezetimibe Tablets CYHS2602544Generic2026/10/14Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Probucol Tablets CYHS2601948Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin Tablets CYHS2601938Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Dapagliflozin Tablets CYHS2601937Generic2026/08/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Ticagrelor Tablets CYHS2504240Generic2025/12/10Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules CYHS2504116Generic2025/11/29Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Ezetimibe and Atorvastatin Calcium Tablets(II) CYHS2503643Generic2025/10/14Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

9 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Bisoprolol Fumarate and Amlodipine Besylate TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202651492026/07/14Generic approved under the new chemical-drug registration classificationCDE ↗
吡格列酮二甲双胍片(I) · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202641542026/04/29Generic approved under the new chemical-drug registration classificationCDE ↗
Atorvastatin Calcium TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202641032026/04/21Generic approved under the new chemical-drug registration classificationCDE ↗
Atorvastatin Calcium TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202641022026/04/21Generic approved under the new chemical-drug registration classificationCDE ↗
Trazodone Hydrochloride TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202631522026/01/20Generic approved under the new chemical-drug registration classificationCDE ↗
Levetiracetam TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202343632023/10/24Generic approved under the new chemical-drug registration classificationCDE ↗
Levetiracetam TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202343622023/10/24Generic approved under the new chemical-drug registration classificationCDE ↗
Rosuvastatin Calcium TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202034642020/09/02Generic approved under the new chemical-drug registration classificationCDE ↗
Rosuvastatin Calcium TabletsZhejiang Jiangbei Pharmaceutical Co., Ltd.Zhejiang Jiangbei Pharmaceutical Co., Ltd.国药准字H202034632020/09/02Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

12 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
瑞舒伐他汀钙 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20220000289A2023/09/27CDE ↗
磷酸西格列汀 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20210000925A2024/01/17CDE ↗
磷酸西格列汀 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20210000387I2021/06/28CDE ↗
利奈唑胺 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20190021444I2020/01/15CDE ↗
依非韦伦 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20190009799A—CDE ↗
辛伐他汀 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20190009704A2025/04/11CDE ↗
辛伐他汀 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20180001496A2024/07/30CDE ↗
左乙拉西坦 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20180001065A2025/11/11CDE ↗
瑞舒伐他汀钙 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20170001629A2024/05/01CDE ↗
埃索美拉唑钠 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20170001319I—CDE ↗
阿托伐他汀钙 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20170000432A2024/10/24CDE ↗
硫酸氢氯吡格雷 · No verified English nameZhejiang Jiangbei Pharmaceutical Co., Ltd.Y20170000089I—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

2 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Escitalopram Oxalate Tablets CYHS2101746Generic2021/09/16Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized; Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗
Escitalopram Oxalate Tablets CYHS2101745Generic2021/09/16Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized; Zhejiang Jiangbei Pharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.